Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Overview
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Companies Involved in Therapeutics Development
Aslan Pharmaceuticals Ltd
Avexegen Therapeutics Inc
Boehringer Ingelheim Intertiol GmbH
Hanmi Pharmaceuticals Co Ltd
HEC Pharm Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
XuanZhu Pharma Co Ltd
Yumab GmbH
Zensun (Shanghai) Sci & Tech Co Ltd
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Drug Profiles
afatinib dimaleate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dacomitinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FCN-411 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KBP-5209 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MIN-301 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Target ErbB4 for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
neratinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Neucardin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NRG-4 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NT-113 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PB-357 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
poziotinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SKLB-1206 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
varlitinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
XZP-5491 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yinlitinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Z-650 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Dormant Products
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Discontinued Products
Receptor Tyrosine Protein Kise ERBB 4 (Tyrosine Kise Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Top 10 Indications, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indications, H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..1), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..2), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..3), H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Products under Development by Companies, H2 2019 (Contd..5), H2 2019
Products under Development by Companies, H2 2019 (Contd..6), H2 2019
Number of Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by Aslan Pharmaceuticals Ltd, H2 2019
Pipeline by Avexegen Therapeutics Inc, H2 2019
Pipeline by Boehringer Ingelheim International GmbH, H2 2019
Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2019
Pipeline by HEC Pharm Co Ltd, H2 2019
Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2 2019
Pipeline by Minerva Neurosciences Inc, H2 2019
Pipeline by Pfizer Inc, H2 2019
Pipeline by Puma Biotechnology Inc, H2 2019
Pipeline by XuanZhu Pharma Co Ltd, H2 2019
Pipeline by Yumab GmbH, H2 2019
Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H2 2019
Dormant Products, H2 2019
Dormant Products, H2 2019 (Contd..1), H2 2019
Dormant Products, H2 2019 (Contd..2), H2 2019
Discontinued Products, H2 2019